Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ivermectin and brimonidine combination in rosacea
IRCT20161207031288N7Phase 2Completed
- Sponsor
- Center for Research and Training in Skin Diseases and Leprosy
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ivermectin and brimonidine in rosacea, sponsored by Center for Research and Training in Skin Diseases and Leprosy. Started Nov 2020; status: completed.
02
Drugs
ivermectinbrimonidine
03
Conditions
rosacea
Beyond the preview
Go deeper on IRCT20161207031288N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161207031288N7.